EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome

Lilia Evans iD, Simon Erridge iD, Madhur Varadpande, Arushika Aggarwal, Isaac Cowley, Evonne Clarke, Katy McLachlan, Ross Coomber, James J Rucker, Michael Platt, Mikael H Sodergren

Brain and Behavior · 2025

DOI: 10.1002/brb3.70823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Lilia Evans und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Cannabis Research Group, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Medical Marijuana, Complex Regional Pain Syndromes. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: John Snow Anaesthesia Intercalated Awards 2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Complex regional pain syndrome is characterized by severe, persistent pain. Emerging evidence suggests that cannabis‐based medicinal products may represent a new therapeutic option. However, to date, no clinical studies have evaluated the effects of cannabis‐based medicinal products in individuals with complex regional pain syndrome. The aim of this study is to assess changes in patient‐reported outcome measures and the prevalence of adverse events associated with cannabis‐based medicinal products prescribed for complex regional pain syndrome.

Methods

This case series assessed changes in patient‐reported outcome measures over 6 months in complex regional pain syndrome patients enrolled in the UK Medical Cannabis Registry. Adverse events were measured and graded using the Common Terminology Criteria for Adverse Events version 4.0.

Results

A total of 64 patients were identified for inclusion. At baseline, pain severity measured by the Brief Pain Inventory Short Form was 6.69 ± 1.42. This improved at 1 (5.85 ± 1.73), 3 (5.91 ± 1.82), and 6 months (6.05 ± 1.72; p < 0.050). Participants also reported improvements in severity as measured by the Short Form‐McGill Pain Questionnaire‐2 and pain visual analogue scale at the same time points ( p < 0.050). Participants also reported improvements in anxiety symptoms, sleep quality, and general health‐related quality of life ( p < 0.050), as measured by validated measures. Five patients (7.81%) reported 50 (78.13%) adverse events.

Discussion

This study represents the outcomes in individuals with complex regional pain syndrome prescribed cannabis‐based medicinal products. These suggest initiation of cannabis‐based medicinal products is associated with improvements in patient‐reported outcome measures. While these findings are consistent with the literature, they must be interpreted with caution, considering the limitations of this study.

Conclusion

Cannabis‐based medicinal products were associated with improvements in pain severity and interference. Participants also reported improvements in important metrics of health‐related quality of life. This supports further research through high‐quality randomized controlled trials to ascertain the efficacy of cannabis‐based medicinal products in improving complex regional pain syndrome symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical MarijuanaComplex Regional Pain SyndromesHumansMaleFemaleRegistriesMiddle AgedAdultUnited KingdomPatient Reported Outcome MeasuresPain MeasurementAgedTreatment OutcomeQuality of Life

Stichwörter der Autor:innen

cannabidiolcannabiscomplex regional pain syndromeshyperalgesiapaintetrahydrocannabinoltrauma

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • Medical Cannabis Research Group, Imperial College London, London, UK.
  • Curaleaf Clinic, London, UK.
  • St. George's Hospital NHS Trust, London, UK.
  • Department of Psychological Medicine, King's College London, London, UK.
  • South London & Maudsley NHS Foundation Trust, London, UK.

ORCID-Profile: Lilia Evans, Simon Erridge

Förderung

  • John Snow Anaesthesia Intercalated Awards 2024

Zitieren

APA

Evans, L., Erridge, S., Varadpande, M., Aggarwal, A., Cowley, I., Clarke, E., McLachlan, K., Coomber, R., Rucker, J. J., Platt, M., & Sodergren, M. H. (2025). UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome. Brain and Behavior. https://doi.org/10.1002/brb3.70823

Vancouver

Evans L, Erridge S, Varadpande M, Aggarwal A, Cowley I, Clarke E, et al. UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome. Brain and Behavior. 2025. doi:10.1002/brb3.70823

BibTeX
@article{Evans2025,
  author = {Evans, Lilia and Erridge, Simon and Varadpande, Madhur and Aggarwal, Arushika and Cowley, Isaac and Clarke, Evonne and McLachlan, Katy and Coomber, Ross and Rucker, James J and Platt, Michael and Sodergren, Mikael H},
  title = {UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70823}
}
Kostenlos starten →